172701-65-4 Usage
Uses
Used in Pharmaceutical Industry:
(NE)-N-(2-chloroacetyl)imino-1-(3-chlorophenyl)-4-methoxy-5-(2-phenylhydrazinyl)pyrazole-3-carboxamide is used as a potential therapeutic agent for targeting specific biological pathways and receptors due to its diverse structure and functional groups.
Used in Medicinal Chemistry Research:
(NE)-N-(2-chloroacetyl)imino-1-(3-chlorophenyl)-4-methoxy-5-(2-phenylhydrazinyl)pyrazole-3-carboxamide is used as a compound for further study and characterization in the field of medicinal chemistry to explore its potential applications and interactions with biological targets.
Check Digit Verification of cas no
The CAS Registry Mumber 172701-65-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,2,7,0 and 1 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 172701-65:
(8*1)+(7*7)+(6*2)+(5*7)+(4*0)+(3*1)+(2*6)+(1*5)=124
124 % 10 = 4
So 172701-65-4 is a valid CAS Registry Number.
InChI:InChI=1/C19H16Cl2N6O3/c1-30-17-16(19(29)25-23-15(28)11-20)26-27(14-9-5-6-12(21)10-14)18(17)24-22-13-7-3-2-4-8-13/h2-10,22,24H,11H2,1H3/b25-23+
172701-65-4Relevant academic research and scientific papers
Synthesis and pharmacological evaluation of some novel 5-(pyrazol-3-yl)thiadiazole and oxadiazole derivatives as potential hypoglycemic agents
Hanna,Girges,Rasala,Gawinecki
, p. 1074 - 1078 (2007/10/02)
Four series of 5-(pyrazol-3-yl)thiadiazole and oxadiazole derivatives (Va-c, VIa-c, VIIIa-c, IXa-c) have been synthesized from 5-arylazo-3-carbethoxy-4-methoxy-1-phenylpyrazole (Ia-c) with a view to investigate their pharmacological activity. The structure of the synthesized products was inferred from elemental and spectral data. The hypoglycemic effect, antimicrobial activity and toxicity of these potential chemotherapeutic agents were evaluated. Nineteen of these products were effective, when administered at an oral dose of 100 mg/kg body weight in inducing a marked reduction in blood glucose level.
